MedPage Today

FDA Approves Monthly Injection Form of Established Schizophrenia Drug Olanzapine

(MedPage Today) -- The FDA approved an easier-to-use once-monthly subcutaneous injectable form of olanzapine (Weltruza) for schizophrenia in adults, Teva Pharmaceuticals announced on Friday. A decades-old drug, olanzapine in its oral form is the...